Lenalidomide

Catalog Number

MC191732726

CAS

191732-72-6

Structure

Synonyms

Leflunomidum;Arava;lefunamide;Lenalidomide;Leflunomide

Molecular Weight

259.26

Molecular Formula

C13H13N3O3

Melting Point

269-271°C

Purity

≥98%

Appearance

Yellow solid

Physical State

Solid

Standard

CP & EP & USP

Description

Revlimid?(trade name Revlimid) is a derivative of thalidomide introduced in 2004.It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Revlimid?has also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Along with several other drugs developed in recent years, Revlimid?has significantly improved overall survival in myeloma (which formerly carried a poor prognosis), although toxicity remains an issue for users. It costs $163,381 per year for the average patient.

MSDS

Download MSDS

Spec Sheet

Download Spec Sheet

Online Inquiry

Name
Phone
* Email
* Quantity
* Service & Products of Interest: Lenalidomide (191732-72-6)
Project Description